Inventor · disambiguated record
Thomas C. Boone
Also filed as: BOONE THOMAS · BOONE THOMAS C · BOONE THOMAS CHARLES
53 granted patents·26 pending applications·1,690 citations·filing 1988–2024
99Inventor score
Top patents by PatentIndex Score
79 records- 0198US6919426B2Peptides and related molecules that modulate nerve growth factor activityAMGEN INC·Filed 2003·Granted Jul 19, 2005·256 cites·3 claims
- 0297US6586398B1Chemically modified novel erythropoietin stimulating protein compositions and methodsAMGEN INC·Filed 2000·Granted Jul 1, 2003·396 cites·5 claims
- 0396US8410043B2Stabilized activin IIB receptor polypeptides and uses thereofSUN JEONGHOON·Filed 2009·Granted Apr 2, 2013·54 cites·15 claims
- 0496US7947809B2Compositions and methods relating to glucagon receptor antibodiesAMGEN INC·Filed 2007·Granted May 24, 2011·46 cites·7 claims
- 0596US6733753B2Composition and method for treating inflammatory diseasesAMGEN INC·Filed 2001·Granted May 11, 2004·73 cites·16 claims
- 0695US9102731B2Human CGRP receptor binding proteinsBOONE THOMAS C·Filed 2009·Granted Aug 11, 2015·39 cites·15 claims
- 0795US7803923B2Polynucleotides encoding myostatin binding agentsAMGEN INC·Filed 2009·Granted Sep 28, 2010·24 cites·15 claims
- 0895US7511012B2Myostatin binding agentsAMGEN INC·Filed 2003·Granted Mar 31, 2009·47 cites·22 claims
- 0994US9273114B2Stabilized receptor polypeptides and uses thereofAMGEN·Filed 2013·Granted Mar 1, 2016·19 cites·31 claims
- 1094US8030025B2Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereofAMGEN INC·Filed 2009·Granted Oct 4, 2011·21 cites·28 claims
- 1194US7008924B1VGF fusion polypeptidesAMGEN INC·Filed 2000·Granted Mar 7, 2006·40 cites·6 claims
- 1294US6294170B1Composition and method for treating inflammatory diseasesAMGEN INC·Filed 1998·Granted Sep 25, 2001·122 cites·15 claims
- 1393US10308704B2Isolated nucleic acid molecules encoding stabilized receptor polypeptides and uses thereofAMGEN INC·Filed 2016·Granted Jun 4, 2019·12 cites·8 claims
- 1493US7928075B2Binding agents which inhibit myostatinAMGEN INC·Filed 2009·Granted Apr 19, 2011·14 cites·9 claims
- 1593US7371559B2Peptides and related molecules that modulate nerve growth factor activityAMGEN INC·Filed 2005·Granted May 13, 2008·21 cites·7 claims
- 1692US5104651AStabilized hydrophobic protein formulations of g-csfAMGEN INC·Filed 1988·Granted Apr 14, 1992·147 cites·22 claims
- 1791US9862771B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2015·Granted Jan 9, 2018·8 cites·36 claims
- 1891US8920798B2Myostatin binding agents, nucleic acids encoding the same, and methods of treatmentAMGEN INC·Filed 2012·Granted Dec 30, 2014·9 cites·28 claims
- 1991US8124724B2Peptides and related molecules that modulate nerve growth factor activityBOONE THOMAS C·Filed 2008·Granted Feb 28, 2012·14 cites·6 claims
- 2091US8071538B2Method of increasing muscle mass by administering a myostatin binding agentHAN HQ·Filed 2010·Granted Dec 6, 2011·14 cites·4 claims
- 2191US2025129172A1Human cgrp receptor binding proteinsAMGEN INC·Filed 2024·Application pending·0 cites
- 2290US6500429B2Antibodies against analogs of brain-derived neurotrophic factorAMGEN INC·Filed 2000·Granted Dec 31, 2002·19 cites·3 claims
- 2389US8158759B2Compositions and methods relating to glucagon receptor antibodiesYAN HAI·Filed 2011·Granted Apr 17, 2012·13 cites·7 claims
- 2487US9562108B2Carrier immunoglobulinsAMGEN INC·Filed 2014·Granted Feb 7, 2017·8 cites·24 claims
- 2586US8513396B2Peptides and related molecules that modulate nerve growth factor activityBOONE THOMAS C·Filed 2012·Granted Aug 20, 2013·9 cites·6 claims
- 2686US6723701B2Protein analogs of brain-derived neurotrophic factorAMGEN INC·Filed 2000·Granted Apr 20, 2004·11 cites·7 claims
- 2785US6617145B2DNA molecules encoding fibrinolytically active polypeptideAMGEN INC·Filed 2001·Granted Sep 9, 2003·17 cites·14 claims
- 2884US8629250B2Hepcidin, hepcidin antagonists and methods of useSASU BARBRA·Filed 2008·Granted Jan 14, 2014·14 cites·15 claims
- 2984US8221749B2Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereofBOONE THOMAS C·Filed 2011·Granted Jul 17, 2012·5 cites·13 claims
- 3084US5849883AMethod for purifying granulocyte colony stimulating factorAMGEN INC·Filed 1996·Granted Dec 15, 1998·82 cites·7 claims
- 3184US2023295267A1Stabilized receptor polypeptides and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 3282US8734796B2Carrier immunoglobulinsWALKER KENNETH W·Filed 2010·Granted May 27, 2014·5 cites·22 claims
- 3380US7553630B2Methods for detecting metalloproteinase inhibitorsAMGEN INC·Filed 2004·Granted Jun 30, 2009·9 cites·12 claims
- 3479US7348162B2Nucleic acids encoding fibroblast growth factor receptor-like proteins and uses thereofAMGEN INC·Filed 2001·Granted Mar 25, 2008·13 cites·11 claims
- 3579US7262166B2Chemically modified novel erythropoietin stimulating protein compositions and methodsAMGEN INC·Filed 2003·Granted Aug 28, 2007·10 cites·16 claims
- 3679US6849450B2Antibodies to the metalloproteinase inhibitorLOS ANGELES CHILDRENS HOSPITAL·Filed 1997·Granted Feb 1, 2005·28 cites·4 claims
- 3777US12134652B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2020·Granted Nov 5, 2024·0 cites·12 claims
- 3877US12122841B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2020·Granted Oct 22, 2024·0 cites·18 claims
- 3973US9562107B2Carrier immunoglobulinsAMGEN INC·Filed 2014·Granted Feb 7, 2017·1 cites·24 claims
- 4072US11685770B2Stabilized receptor polypeptides and uses thereofAMGEN INC·Filed 2019·Granted Jun 27, 2023·0 cites·6 claims
- 4170US8992925B2RANKL antibody-PTH/PTHrP chimeric moleculesKOSTENUIK PAUL·Filed 2006·Granted Mar 31, 2015·2 cites·62 claims
- 4267US7195903B2Methods for the treatment of thrombosisAMGEN INC·Filed 2003·Granted Mar 27, 2007·2 cites·29 claims
- 4366US2015175687A1Myostatin binding agentsAMGEN INC·Filed 2014·Application pending·0 cites
- 4465US2025066443A1Compositions comprising truncated interleukin-33 and interleukin-2SLATE BIO INC·Filed 2024·Application pending·0 cites
- 4564US2018142029A1Human cgrp receptor binding proteinsAMGEN INC·Filed 2017·Application pending·0 cites
- 4662US5606024ACanine G-CSF polypeptides and pharmaceutical compositions comprising sameAMGEN INC·Filed 1995·Granted Feb 25, 1997·22 cites·4 claims
- 4762US2005143294A1Analogs of cationic proteinsAMGEN INC·Filed 2003·Application pending·0 cites
- 4862US2007049532A1Modified peptides as therapeutic agentsAMGEN INC·Filed 2006·Application pending·0 cites
- 4961US2013336992A1Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereofAMGEN INC·Filed 2013·Application pending·0 cites
- 5060US10336820B2Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereofAMGEN INC·Filed 2016·Granted Jul 2, 2019·0 cites·17 claims
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas C. Boone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →